GNSS vs TECH · $76.3M cap vs P/E 65, rev $1.22B
Genasys Inc (GNSS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Genasys Inc (GNSS) is a scientific & technical instruments company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
GNSS does not have a complete income-statement cache yet.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GNSS currently screens at market cap $76.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GNSS and TECH stock pages for the full models.
Not investment advice.